These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27612613)

  • 1. Association of Chemerin and Vascular Endothelial Growth Factor (VEGF) with Diabetic Nephropathy.
    Lin S; Teng J; Li J; Sun F; Yuan D; Chang J
    Med Sci Monit; 2016 Sep; 22():3209-14. PubMed ID: 27612613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of fosinopril on chemerin and VEGF expression in diabetic nephropathy rats.
    Huang H; Hu L; Lin J; Zhu X; Cui W; Xu W
    Int J Clin Exp Pathol; 2015; 8(9):11470-4. PubMed ID: 26617877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemerin/ChemR23 axis promotes inflammation of glomerular endothelial cells in diabetic nephropathy.
    Shang J; Wang L; Zhang Y; Zhang S; Ning L; Zhao J; Cheng G; Liu D; Xiao J; Zhao Z
    J Cell Mol Med; 2019 May; 23(5):3417-3428. PubMed ID: 30784180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of extract of Pueraria tuberosa on expression of hypoxia inducible factor-1α and vascular endothelial growth factor in kidney of diabetic rats.
    Shukla R; Pandey N; Banerjee S; Tripathi YB
    Biomed Pharmacother; 2017 Sep; 93():276-285. PubMed ID: 28648975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of Cordyceps sinensis on expressions of HIF-1α and VEGF in the kidney of rats with diabetic nephropathy].
    Yuan M; Tang R; Zhou Q; Liu K; Xiao Z; Pouranan V
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 May; 38(5):448-57. PubMed ID: 23719521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effects of VEGF-R inhibitor on podocytopathy of rats with type I diabetic nephropathy].
    Wang S; Li Y; Huang YJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Sep; 27(9):1003-6. PubMed ID: 21906476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation Analysis of Vascular Endothelial Growth Factor Level with Clinicopathological Features and Prognosis in Patients with Diabetic Nephropathy: A Biopsy-based Study.
    Zhang J; Zhu H; Tang Q; Wu J
    Cell Mol Biol (Noisy-le-grand); 2023 Aug; 69(8):192-197. PubMed ID: 37715389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regulatory effect of compound Coptidis Rhizoma capsule on unbalanced expression of renal tissue TGF-β1/BMP-7 and Smad signaling pathway in rats with early diabetic nephropathy].
    Liu S; Chen XQ; Tang LQ; Yu N; Zhang XL; Du HF
    Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(5):938-45. PubMed ID: 26087560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of extremely low frequency pulsed magnetic fields on diabetic nephropathy in streptozotocin-treated rats.
    Li F; Lei T; Xie K; Wu X; Tang C; Jiang M; Liu J; Luo E; Shen G
    Biomed Eng Online; 2016 Jan; 15():8. PubMed ID: 26786255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of SOCS1 on diabetic renal injury through regulating TLR signaling pathway.
    Wu XY; Yu J; Tian HM
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8068-8074. PubMed ID: 31599432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMKLR1 Antagonist Alpha-NETA Protects against Diabetic Nephropathy in Mice.
    Peng Z; Wang X; Zhu Q; Wang H; Li B; Pang X; Han J
    Kidney Blood Press Res; 2023; 48(1):405-413. PubMed ID: 37231814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amelioration of diabetic nephropathy in db/db mice treated with tibetan medicine formula Siwei Jianghuang Decoction Powder extract.
    Lai X; Tong D; Ai X; Wu J; Luo Y; Zuo F; Wei Z; Li Y; Huang W; Wang W; Jiang Q; Meng X; Zeng Y; Wang P
    Sci Rep; 2018 Nov; 8(1):16707. PubMed ID: 30420600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-β1 and connective tissue growth factor in streptozotocin-induced diabetic rats.
    Lai PB; Zhang L; Yang LY
    Ren Fail; 2012; 34(1):83-7. PubMed ID: 22011322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urocortin 1 improves renal function in rats with streptozotocin-induced diabetes by inhibiting overproduction of TGF-beta 1 and VEGF.
    Li X; Hu J; Zhang Q; Sun X; Li S
    Br J Pharmacol; 2009 Jul; 157(6):994-1003. PubMed ID: 19466989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation between expressions of VEGF and TRPC6 and their roles in podocyte injury in rats with diabetic nephropathy].
    Zhu XN; Wang YH; Wu JJ; Dong P; Zhang M
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Mar; 38(3):296-304. PubMed ID: 29643035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosiglitazone ameliorates diabetic nephropathy by reducing the expression of Chemerin and ChemR23 in the kidney of streptozotocin-induced diabetic rats.
    Hu W; Yu Q; Zhang J; Liu D
    Inflammation; 2012 Aug; 35(4):1287-93. PubMed ID: 22350950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roux-en-Y Esophagojejunostomy Ameliorates Renal Function Through Reduction of Renal Inflammatory and Fibrotic Markers in Diabetic Nephropathy.
    Wang C; He B; Piao D; Han P
    Obes Surg; 2016 Jul; 26(7):1402-13. PubMed ID: 26510754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy.
    Lindenmeyer MT; Kretzler M; Boucherot A; Berra S; Yasuda Y; Henger A; Eichinger F; Gaiser S; Schmid H; Rastaldi MP; Schrier RW; Schlöndorff D; Cohen CD
    J Am Soc Nephrol; 2007 Jun; 18(6):1765-76. PubMed ID: 17475821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
    Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
    J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemerin/chemR23 association with endothelial-mesenchymal transition in diabetic nephropathy.
    Wang X; Guo J; Wu Q; Niu C; Cheng G; Liu D; Liu Z; Zhao Z; Xiao J
    Int J Clin Exp Pathol; 2017; 10(7):7408-7416. PubMed ID: 31966583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.